Crinetics (CRNX) announced that the European Medicines Agency has validated the marketing authorization application for paltusotine, the first ...
US biotech Exelixis (Nasdaq: EXEL) has secured a sixth indication for its cancer drug Cabometyx (cabozantinib), following a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback